Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-14

Clinical Trial Update: Butylphthalide for Brain Edema After Endovascular Treatment [Phase 4]

View source ↗

Summary

An update indicates a Phase 4 trial is evaluating butylphthalide for brain edema after endovascular treatment in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butylphthalide (butylphthalide)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Ischemic Stroke | Phase 4 | Status: NOT_YET_RECRUITING